5.50 pm | 24 Jul 2008

Plethico Pharmaceuticals revenues FTQ at INR 240.40 crores and PAT at INR 49.89 crores and YTM at INR 481 crores and INR 90.65 crores respectively...

2.47 pm | 16 Jul 2008 |  Source: CNBC-TV18

Ashish Maheshwari, MD of India Capital Markets is of the view that one can expect 30% upside in Plethico Pharma in 12 months time. It is in a high mar...

5.20 pm | 30 Jun 2008

Plethico Pharmaceuticals is looking at trimming its Contract Research and Manufacturing Services business as low margins are being further squeezed du...

3.30 pm | 26 Jun 2008 |  Source: Moneycontrol.com

SPA Securities has recommended a buy rating on Plethico Pharmaceuticals with a 12-month target price of Rs 475. At the CMP of Rs 381.80, the stock is ...

3.02 pm | 18 Jun 2008 |  Source: CNBC-TV18

Midcap pharma stocks are on the roll. What are the key triggers? Cadila Healthcare would be consolidating and restructuring its consumer products divi...

12.43 pm | 16 Jun 2008 |  Source: Moneycontrol.com

Emkay PCR has maintained buy rating on Plethico Pharma with target price of Rs 569. price of Rs 569. Post recommendation the scrip touched the peak o...

5.30 pm | 28 Apr 2008

Plethico Pharmaceuticals revenues at INR 128.30 crores and PAT at INR 31.98 crores...

1.55 pm | 28 Apr 2008 |  Source: Moneycontrol.com

Plethico Pharma has anounced its first quarter results. The consolidated net profit was at Rs 40.75 crore versus Rs 27 crore....

12.54 pm | 04 Apr 2008 |  Source: Moneycontrol.com

Emkay Research has maintained a but rating on Plethico Pharma with a target price of Rs 569. The stock is currently trading at 9.0x FY08E EPS of Rs 43...